Cargando…

Substance Use During Imprisonment in Low- and Middle-Income Countries

Substance use disorders are among the most common health problems of people involved with the criminal justice system. Scaling up addiction services in prisons is a global public health and human rights challenge, especially in poorly resourced countries. We systematically reviewed the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundt, Adrian P, Baranyi, Gergő, Gabrysch, Caroline, Fazel, Seena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982797/
https://www.ncbi.nlm.nih.gov/pubmed/29584860
http://dx.doi.org/10.1093/epirev/mxx016
_version_ 1783328312667406336
author Mundt, Adrian P
Baranyi, Gergő
Gabrysch, Caroline
Fazel, Seena
author_facet Mundt, Adrian P
Baranyi, Gergő
Gabrysch, Caroline
Fazel, Seena
author_sort Mundt, Adrian P
collection PubMed
description Substance use disorders are among the most common health problems of people involved with the criminal justice system. Scaling up addiction services in prisons is a global public health and human rights challenge, especially in poorly resourced countries. We systematically reviewed the prevalence of substance use in prison populations in low- and middle-income countries. We searched for studies reporting prevalence rates of nicotine, alcohol, illicit drug, and injection drug use during imprisonment in unselected samples of imprisoned people in low- and middle-income countries. Data meta-analysis was conducted and sources of heterogeneity were examined by meta-regression. Prevalence of nicotine use during imprisonment ranged from 5% to 87%, with a random-effects pooled estimate of 56% (95% confidence interval (CI): 45, 66) with significant geographical heterogeneity. Alcohol use varied from 1% to 76% (pooled prevalence, 16%, 95% CI: 9, 25). Approximately one-quarter of people (25%; 95% CI: 17, 33; range, 0–78) used illicit drugs during imprisonment. The prevalence of injection drug use varied from 0% to 26% (pooled estimate, 1.6%, 95% CI: 0.8, 3.0). Lifetime substance use was investigated in secondary analyses. The high prevalence of smoking in prison suggests that policies regarding smoking need careful review. Furthermore, the findings underscore the importance of timely, scalable, and available treatments for alcohol and illegal drug use by people involved with the criminal justice system.
format Online
Article
Text
id pubmed-5982797
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-59827972018-06-06 Substance Use During Imprisonment in Low- and Middle-Income Countries Mundt, Adrian P Baranyi, Gergő Gabrysch, Caroline Fazel, Seena Epidemiol Rev Review Substance use disorders are among the most common health problems of people involved with the criminal justice system. Scaling up addiction services in prisons is a global public health and human rights challenge, especially in poorly resourced countries. We systematically reviewed the prevalence of substance use in prison populations in low- and middle-income countries. We searched for studies reporting prevalence rates of nicotine, alcohol, illicit drug, and injection drug use during imprisonment in unselected samples of imprisoned people in low- and middle-income countries. Data meta-analysis was conducted and sources of heterogeneity were examined by meta-regression. Prevalence of nicotine use during imprisonment ranged from 5% to 87%, with a random-effects pooled estimate of 56% (95% confidence interval (CI): 45, 66) with significant geographical heterogeneity. Alcohol use varied from 1% to 76% (pooled prevalence, 16%, 95% CI: 9, 25). Approximately one-quarter of people (25%; 95% CI: 17, 33; range, 0–78) used illicit drugs during imprisonment. The prevalence of injection drug use varied from 0% to 26% (pooled estimate, 1.6%, 95% CI: 0.8, 3.0). Lifetime substance use was investigated in secondary analyses. The high prevalence of smoking in prison suggests that policies regarding smoking need careful review. Furthermore, the findings underscore the importance of timely, scalable, and available treatments for alcohol and illegal drug use by people involved with the criminal justice system. Oxford University Press 2018-06 2018-03-23 /pmc/articles/PMC5982797/ /pubmed/29584860 http://dx.doi.org/10.1093/epirev/mxx016 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mundt, Adrian P
Baranyi, Gergő
Gabrysch, Caroline
Fazel, Seena
Substance Use During Imprisonment in Low- and Middle-Income Countries
title Substance Use During Imprisonment in Low- and Middle-Income Countries
title_full Substance Use During Imprisonment in Low- and Middle-Income Countries
title_fullStr Substance Use During Imprisonment in Low- and Middle-Income Countries
title_full_unstemmed Substance Use During Imprisonment in Low- and Middle-Income Countries
title_short Substance Use During Imprisonment in Low- and Middle-Income Countries
title_sort substance use during imprisonment in low- and middle-income countries
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982797/
https://www.ncbi.nlm.nih.gov/pubmed/29584860
http://dx.doi.org/10.1093/epirev/mxx016
work_keys_str_mv AT mundtadrianp substanceuseduringimprisonmentinlowandmiddleincomecountries
AT baranyigergo substanceuseduringimprisonmentinlowandmiddleincomecountries
AT gabryschcaroline substanceuseduringimprisonmentinlowandmiddleincomecountries
AT fazelseena substanceuseduringimprisonmentinlowandmiddleincomecountries